AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Illinois and currently employs 55,000 full-time employees. The company went IPO on 2013-01-02. The firm is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Its Immunology products include rheumatology, dermatology and gastroenterology. Its Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere, and Epkinly. The Company’s Aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Its Eye Care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and Other eye care. Its Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its Venclexta is a B-cell lymphoma 2 (BCL-2) inhibitor used to treat blood cancers.
Follow-Up Questions
AbbVie Inc (ABBV)'in P/E oranı nedir?
AbbVie Inc 'in P/E oranı 95.1001 'dir
AbbVie Inc 'in CEO'su kimdir?
Mr. Robert Michael 2017 'den beri şirketle birlikte olan AbbVie Inc 'in Chairman of the Board 'ıdır.
ABBV hissesinin fiyat performansı nasıl?
ABBV 'in mevcut fiyatı $217.02 'dir, son işlem günde 0.46% decreased etti.
AbbVie Inc için ana iş temaları veya sektörler nelerdir?
AbbVie Inc Biotechnology endüstrisine ait ve sektör Health Care 'dir
AbbVie Inc 'in piyasa değerlemesi nedir?
AbbVie Inc 'in mevcut piyasa değerlemesi $383.3B 'dir
AbbVie Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 31 analist AbbVie Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 9 güçlü al, 17 al, 11 tut, 0 sat ve 9 güçlü sat içermektedir
